Brief: VBI Vaccines Announces Filing Of New Drug Submission For 3-Antigen Hepatitis B Vaccine To Health Canada
09/12/2021 13:06
Dec 9 (Reuters) - VBI Vaccines Inc VBIV.O :
* VBI VACCINES ANNOUNCES FILING OF NEW DRUG SUBMISSION FOR
3-ANTIGEN HEPATITIS B VACCINE TO HEALTH CANADA
Source text for Eikon: ID:nBw95NWysa
Further company coverage: VBIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VBI Vaccines
See all newsBrief: VBI Vaccines Provides Update On Its Restructuring Proceedings
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55